(Q33763932)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

C P Warlow

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

9188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1457-1463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

Assessment of clinical outcomes in acute stroke trials

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

The American Heart Association Stroke Outcome Classification.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Finding information on clinical effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Stroke: how large a public health problem, and how can the neurologist help?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Confidence intervals for the number needed to treat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth population-based stroke registers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Predicting survival for 1 year among different subtypes of stroke. Results from the Perth Community Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Prevalence of Stroke and Stroke-Related Disability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Long-term risk of first recurrent stroke in the Perth Community Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Costs of medical care after first-ever stroke in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Smoking and risk of stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

One year after CAPRIE, IST and ESPS 2. Any changes in concepts?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

The following is a list of major ongoing studies about stroke. Information about other multicenter studies that might be included in this list should be submitted to the stroke editorial office by the principal investigator. The list will appear in

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

The prognosis of hospital-referred transient ischaemic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Changing practice and costs of carotid endarterectomy in Toronto, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Lifetime cost of stroke in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2904407-4

7 January 2021

10.1016/S0140-6736(99)04407-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10543686%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference